BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35979650)

  • 21. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11.
    Baert A; Machackova E; Coene I; Cremin C; Turner K; Portigal-Todd C; Asrat MJ; Nuk J; Mindlin A; Young S; MacMillan A; Van Maerken T; Trbusek M; McKinnon W; Wood ME; Foulkes WD; Santamariña M; de la Hoya M; Foretova L; Poppe B; Vral A; Rosseel T; De Leeneer K; Vega A; Claes KBM
    Hum Mutat; 2018 Apr; 39(4):515-526. PubMed ID: 29280214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations.
    Colombo M; De Vecchi G; Caleca L; Foglia C; Ripamonti CB; Ficarazzi F; Barile M; Varesco L; Peissel B; Manoukian S; Radice P
    PLoS One; 2013; 8(2):e57173. PubMed ID: 23451180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bypass of premature stop codons and generation of functional BRCA2 by exon skipping.
    Stauffer S; Biswas K; Sharan SK
    J Hum Genet; 2020 Sep; 65(9):805-809. PubMed ID: 32393813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUP.
    Walker LC; de la Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison S; Spurdle AB
    medRxiv; 2023 Feb; ():. PubMed ID: 36865205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
    Tesoriero AA; Wong EM; Jenkins MA; Hopper JL; Brown MA; Chenevix-Trench G; Spurdle AB; Southey MC;
    Hum Mutat; 2005 Nov; 26(5):495. PubMed ID: 16211554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using
    Tubeuf H; Caputo SM; Sullivan T; Rondeaux J; Krieger S; Caux-Moncoutier V; Hauchard J; Castelain G; Fiévet A; Meulemans L; Révillion F; Léoné M; Boutry-Kryza N; Delnatte C; Guillaud-Bataille M; Cleveland L; Reid S; Southon E; Soukarieh O; Drouet A; Di Giacomo D; Vezain M; Bonnet-Dorion F; Bourdon V; Larbre H; Muller D; Pujol P; Vaz F; Audebert-Bellanger S; Colas C; Venat-Bouvet L; Solano AR; Stoppa-Lyonnet D; Houdayer C; Frebourg T; Gaildrat P; Sharan SK; Martins A
    Cancer Res; 2020 Sep; 80(17):3593-3605. PubMed ID: 32641407
    [No Abstract]   [Full Text] [Related]  

  • 28. Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.
    Whiley PJ; Guidugli L; Walker LC; Healey S; Thompson BA; Lakhani SR; Da Silva LM; ; Tavtigian SV; Goldgar DE; Brown MA; Couch FJ; Spurdle AB
    Hum Mutat; 2011 Jun; 32(6):678-87. PubMed ID: 21394826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of spliceogenic variants located in regions linked to high levels of alternative splicing: BRCA2 c.7976+5G > T as a case study.
    Montalban G; Fraile-Bethencourt E; López-Perolio I; Pérez-Segura P; Infante M; Durán M; Alonso-Cerezo MC; López-Fernández A; Diez O; de la Hoya M; Velasco EA; Gutiérrez-Enríquez S
    Hum Mutat; 2018 Sep; 39(9):1155-1160. PubMed ID: 29969168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skipping Nonsense to Maintain Function: The Paradigm of
    Meulemans L; Mesman RLS; Caputo SM; Krieger S; Guillaud-Bataille M; Caux-Moncoutier V; Léone M; Boutry-Kryza N; Sokolowska J; Révillion F; Delnatte C; Tubeuf H; Soukarieh O; Bonnet-Dorion F; Guibert V; Bronner M; Bourdon V; Lizard S; Vilquin P; Privat M; Drouet A; Grout C; Calléja FMGR; Golmard L; Vrieling H; Stoppa-Lyonnet D; Houdayer C; Frebourg T; Vreeswijk MPG; Martins A; Gaildrat P
    Cancer Res; 2020 Apr; 80(7):1374-1386. PubMed ID: 32046981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
    Colombo M; Lòpez-Perolio I; Meeks HD; Caleca L; Parsons MT; Li H; De Vecchi G; Tudini E; Foglia C; Mondini P; Manoukian S; Behar R; Garcia EBG; Meindl A; Montagna M; Niederacher D; Schmidt AY; Varesco L; Wappenschmidt B; Bolla MK; Dennis J; Michailidou K; Wang Q; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadel A; Benitez J; Boeckx B; Bogdanova NV; Bojesen SE; Bonanni B; Brauch H; Brenner H; Burwinkel B; Chang-Claude J; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Eriksson M; Fasching PA; Figueroa J; Fletcher O; Flyger H; Gabrielson M; García-Closas M; Giles GG; González-Neira A; Guénel P; Haiman CA; Hall P; Hamann U; Hartman M; Hauke J; Hollestelle A; Hopper JL; Jakubowska A; Jung A; Kosma VM; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Margolin S; Miao H; Milne RL; Neuhausen SL; Nevanlinna H; Olson JE; Peterlongo P; Peto J; Pylkäs K; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; See MH; Southey MC; Swerdlow A; Teo SH; Toland AE; Tomlinson I; Truong T; van Asperen CJ; van den Ouweland AMW; van der Kolk LE; Winqvist R; Yannoukakos D; Zheng W; ; Dunning AM; Easton DF; Henderson A; Hogervorst FBL; Izatt L; Offitt K; Side LE; van Rensburg EJ; Embrace S; Hebon S; McGuffog L; Antoniou AC; Chenevix-Trench G; Spurdle AB; Goldgar DE; Hoya M; Radice P
    Hum Mutat; 2018 May; 39(5):729-741. PubMed ID: 29460995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.
    Fackenthal JD; Yoshimatsu T; Zhang B; de Garibay GR; Colombo M; De Vecchi G; Ayoub SC; Lal K; Olopade OI; Vega A; Santamariña M; Blanco A; Wappenschmidt B; Becker A; Houdayer C; Walker LC; López-Perolio I; Thomassen M; Parsons M; Whiley P; Blok MJ; Brandão RD; Tserpelis D; Baralle D; Montalban G; Gutiérrez-Enríquez S; Díez O; Lazaro C; ; Spurdle AB; Radice P; de la Hoya M
    J Med Genet; 2016 Aug; 53(8):548-58. PubMed ID: 27060066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
    Vreeswijk MP; Kraan JN; van der Klift HM; Vink GR; Cornelisse CJ; Wijnen JT; Bakker E; van Asperen CJ; Devilee P
    Hum Mutat; 2009 Jan; 30(1):107-14. PubMed ID: 18693280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
    Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
    Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.
    Wappenschmidt B; Becker AA; Hauke J; Weber U; Engert S; Köhler J; Kast K; Arnold N; Rhiem K; Hahnen E; Meindl A; Schmutzler RK
    PLoS One; 2012; 7(12):e50800. PubMed ID: 23239986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes.
    Montalban G; Bonache S; Moles-Fernández A; Gadea N; Tenés A; Torres-Esquius S; Carrasco E; Balmaña J; Diez O; Gutiérrez-Enríquez S
    Hum Mutat; 2019 Dec; 40(12):2296-2317. PubMed ID: 31343793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel BRCA2 splice variant identified in a young woman.
    Nicolussi A; Belardinilli F; Ottini L; Petroni M; Capalbo C; Giannini G; Coppa A
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1513. PubMed ID: 33159495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing.
    Brandão RD; van Roozendaal K; Tserpelis D; Gómez García E; Blok MJ
    Breast Cancer Res Treat; 2011 Oct; 129(3):971-82. PubMed ID: 21638052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
    de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB
    Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.